Ruml L A, Pearle M S, Pak C Y
Center for Mineral Metabolism and Clinical Research, University of Texas, Southwestern Medical Center, Dallas, USA.
Urol Clin North Am. 1997 Feb;24(1):117-33. doi: 10.1016/s0094-0143(05)70358-x.
The development of diagnostic protocols that identify specific risk factors for calcium oxalate nephrolithiasis has led to the formulation of directed medical regimens that are aimed at correcting the underlying metabolic disturbances. Initiation of these treatment programs has reduced markedly the rate of stone formation in the majority of patients who form stones. This article discusses the rationale that underlies the choice of medical therapy for the various pathophysiologic causes of calcium oxalate nephrolithiasis and the appropriate use of available medications.
用于识别草酸钙肾结石特定风险因素的诊断方案的发展,已促成了旨在纠正潜在代谢紊乱的针对性医疗方案的制定。启动这些治疗方案已显著降低了大多数结石形成患者的结石形成率。本文讨论了针对草酸钙肾结石各种病理生理原因选择药物治疗的基本原理以及现有药物的合理使用。